Affymetrix expects the acquisition of eBioscience to: • Create significant new commercial opportunities in the key post-genomic applications of immunology, oncology, cell biology, stem cell biology, ...
Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of ...
Affymetrix, Inc. (NASDAQ:AFFX) today launched the GeneChip(R) miRNA 2.0 Array. This enhanced version of its best-in-class microRNA (miRNA) interrogation solution will support the research community's ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
BANGALORE (Reuters) - Affymetrix Inc , which makes arrays to analyze genetic data, forecast third-quarter revenue below analysts' estimates, citing increased competition for academic research funding ...
(Reuters) - Gene sequencing products maker Affymetrix Inc delayed a shareholder voting on its deal to be acquired by Thermo Fisher Scientific Inc , saying a raised offer from its former executives ...
Can a single word in a 35,000-word merger agreement cause a buyer to lose a deal to a higher bidder? In the case of Thermo Fisher Scientific Inc.’s pending buyout of Affymetrix Inc., it’s possible.
Xcel microarray is built around Affymetrix’ Human Genome U133 Plus 2.0 array. Affymetrix negotiated exclusive distribution rights to Almac Group’s Xcel™ array microarray, which has been developed for ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
Microarray giant Affymetrix http://www.affymetrix.com of Santa Clara, Calif., is raising the bar for whole-genome association studies. The first in a planned line of ...
Affymetrix, Inc. has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results